Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?-Reference-Cited by-同舟云学术

Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?

Published:2024-03-04 Issue:18 Volume:45 Page:1593-1595
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Vergallo Rocco¹²^ORCID,Galiuto Leonarda³^ORCID

Affiliation:

1. Interventional Cardiology Unit, Cardiothoracic and Vascular Department (DICATOV), IRCCS Ospedale Policlinico San Martino , Largo R. Benzi, 10, 16132 Genova , Italy

2. Department of Internal Medicine and Medical Specialties (DIMI), Università di Genova , Viale Benedetto XV, 6, Genova 16132 , Italy

3. Department of Clinical and Molecular Medicine, Sapienza University of Rome, Azienda Ospedaliero-Universitaria S. Andrea , Rome , Italy

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/eurheartj/article-pdf/45/18/1593/57567961/ehae119.pdf

Reference12 articles.

1. Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial;Iglesias;Lancet,2023

2. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial;Iglesias;Lancet,2019

3. Biodegradable- versus durable-polymer drug-eluting stents for STEMI: final 2-year outcomes of the BIOSTEMI trial;Pilgrim;JACC Cardiovasc Interv,2021

4. Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial;Pilgrim;Lancet,2018

5. 2023 ESC guidelines for the management of acute coronary syndromes;Byrne;Eur Heart J,2023